Y. Miyata

Clinical trial of MCC-465, a doxorubicin encapsulated in PEG-immunoliposome, in patients with metastatic stomach cancer

Y. Matsumura, T. Hamaguchi, K. Shirao, 2004 .

Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancer.

Y. Shimada, S. Matsumoto, K. Muro, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.